6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
1h ago	Pinnacle Silver and Gold Commences Trading on OTCQB
1h ago	Apogee Minerals Announces Non-Brokered Private Placement Financing
1h ago	Honey Badger Silver Closes Transformative Acquisition of the Important PC Silver Project in the Northwest Territories
1h ago	Mayfair Gold Provides Update on Project Work in the First Quarter of 2026 Advancing and Derisking the Fenn-Gib Gold Project
1h ago	Faraday Future Strategically Launches Its Embodied AI Developer Platform Purpose-Built for AI Natives, Marking 2026 as the Inaugural Year of EAI Robotics Education

About

Hls Therapeutics Inc (TO:HLS) — investor relations, events, news, and company updates on 6ix.

Latest News

HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

HLS Therapeutics Announces Fiscal 2025 Financial Results

HLS Therapeutics Announces NILEMDOTM (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease

HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call

Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

Financials

Revenue

CA$55.5 M

Market Cap

CA$137.6 M

EPS

-0.54

Community Chat

Ask AI